These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 39004655)
1. Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems. Tsakiris DA; Gavriilaki E; Chanou I; Meyer SC Bone Marrow Transplant; 2024 Oct; 59(10):1349-1359. PubMed ID: 39004655 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role? Lia G; Giaccone L; Leone S; Bruno B Front Immunol; 2021; 12():641427. PubMed ID: 34093530 [TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
4. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Lewis C; Kim HT; Roeker LE; Cutler C; Koreth J; Nikiforow S; Armand P; Gootpu M; Romee R; Glotzbecker B; Nageshwar P; Antin JH; Alyea EP; Richardson P; Soiffer RJ; Ho VT Biol Blood Marrow Transplant; 2020 Mar; 26(3):529-539. PubMed ID: 31678537 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation. Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527 [TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis. Eftychidis I; Sakellari I; Anagnostopoulos A; Gavriilaki E Expert Rev Hematol; 2021 Sep; 14(9):831-840. PubMed ID: 34388057 [TBL] [Abstract][Full Text] [Related]
9. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation. Hildebrandt GC; Chao N Br J Haematol; 2020 Aug; 190(4):508-519. PubMed ID: 32319084 [TBL] [Abstract][Full Text] [Related]
10. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report. Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585 [TBL] [Abstract][Full Text] [Related]
11. Interplay of Inflammation and Endothelial Dysfunction in Bone Marrow Transplantation: Focus on Hepatic Veno-Occlusive Disease. Vion AC; Rautou PE; Durand F; Boulanger CM; Valla DC Semin Thromb Hemost; 2015 Sep; 41(6):629-43. PubMed ID: 26305238 [TBL] [Abstract][Full Text] [Related]
12. Incidence and Role of Recipient-Specific Antibodies in Allogeneic Hematopoietic Cell Transplantation from Mismatched Related Donors. Sadowska-Klasa A; Dukat-Mazurek A; Zielińska H; Dębska-Zielkowska J; Piekarska A; Moszkowska G; Mensah-Glanowska P; Zaucha JM Transplant Cell Ther; 2024 Jan; 30(1):99.e1-99.e10. PubMed ID: 37875214 [TBL] [Abstract][Full Text] [Related]
13. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation. Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271 [TBL] [Abstract][Full Text] [Related]